Literature DB >> 17963865

A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe.

Ariane van der Straten1, Sue Napierala, Helen Cheng, Christine Mauck, Teresa Depineres, Patricia Dhlakama, Marin Thompson, Tsungai Chipato, Nii Hammond, Nancy Padian.   

Abstract

BACKGROUND: Cellulose sulfate (CS) is an antimicrobial and contraceptive agent. We assessed its safety when used alone or with the diaphragm in Harare, Zimbabwe. STUDY
DESIGN: This was a randomized controlled safety trial with three arms: diaphragm with 6% CS gel vs. diaphragm with KY gel vs. CS gel alone. Participants were instructed to use their study products before every sex act for a period of 6 months. Safety end points were assessed monthly by questionnaires and urinanalysis and bimonthly by clinical examinations, colposcopy, wet mounts and gram stains.
RESULTS: One hundred nineteen monogamous women were enrolled (28% HIV+) and 105 (88%) completed the study. No urinary tract infections were diagnosed during the study; 81.4% women had symptoms and/or signs of genital irritation considered at least possibly related to the gel or device, and 41.5% had changes in vaginal flora. There were no statistically significant differences between treatment groups in safety end points. All six women with deep epithelial disruption were diaphragm users, and all such findings were on the external genitalia. Of those, 4 had herpetic ulcers which were unrelated to products use.
CONCLUSIONS: Cellulose sulfate appeared safe when used for 6 months alone or with a diaphragm.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963865     DOI: 10.1016/j.contraception.2007.07.004

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  8 in total

1.  In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides.

Authors:  Youssef Gali; Olivier Delezay; Joachim Brouwers; Noura Addad; Patrick Augustijns; Thomas Bourlet; Hind Hamzeh-Cognasse; Kevin K Ariën; Bruno Pozzetto; Guido Vanham
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Prevalence and risks for bacterial vaginosis in women who have sex with women.

Authors:  Jeanne M Marrazzo; Katherine K Thomas; Kathy Agnew; Kathleen Ringwood
Journal:  Sex Transm Dis       Date:  2010-05       Impact factor: 2.830

3.  Bridewealth and sexual and reproductive practices among women in Harare, Zimbabwe.

Authors:  Janet M Wojcicki; Ariane van der Straten; Nancy Padian
Journal:  AIDS Care       Date:  2010-06

4.  Topical microbicides for preventing sexually transmitted infections.

Authors:  Jael Obiero; Paul Ogongo; Peter G Mwethera; Charles S Wiysonge
Journal:  Cochrane Database Syst Rev       Date:  2021-03-13

5.  Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1.

Authors:  Vanessa Pirrone; Shendra Passic; Brian Wigdahl; Fred C Krebs
Journal:  Virol J       Date:  2012-01-26       Impact factor: 4.099

6.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

7.  Diaphragm used with replens gel and risk of bacterial vaginosis: results from a randomized controlled trial.

Authors:  Craig R Cohen; Su-Chun Cheng; Stephen Shiboski; Tsungai Chipato; Martin Matu; James Mwangi; Monalisa E S Mutimutema; Jennifer Tuveson; Mavis Kamba; Nancy Padian; Ariane van der Straten
Journal:  Infect Dis Obstet Gynecol       Date:  2012-10-24

Review 8.  Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis.

Authors:  Jael Obiero; Peter G Mwethera; Gregory D Hussey; Charles S Wiysonge
Journal:  BMC Infect Dis       Date:  2012-11-06       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.